Analyst consensus rating
Anixa Biosciences Analyst Rating: none
ANIX is rated none by 4 analysts with a $10.00 target. As of 2026-08-30.
Direct answer
Anixa Biosciences's consensus rating is none.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $10.00.
Forecast evidence checked August 30, 2026.
Get free Anixa Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.48
- Average price target
- $10.00
- High price target
- $14.00
- Low price target
- $7.00
- Low target gap
- +101.1%
- Target upside
- +187.4%
- High target gap
- +302.3%
- Target range width
- 201.1%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- August 30, 2026
- Valid through
- September 6, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Anixa Biosciences?
Anixa Biosciences has a verified none consensus. The same dataset has an average price target of $10.00.
How far are Anixa Biosciences's low and high targets from the recorded price?
The low target implies +101.1%, while the high target implies +302.3%.
How many analysts are included in Anixa Biosciences's consensus?
The verified consensus includes 4 analysts.
How is Anixa Biosciences's target upside or downside calculated?
The average target of $10.00 is divided by the recorded price of $3.48, then one is subtracted to produce +187.4%. This does not guarantee a future return.
When was Anixa Biosciences's analyst forecast verified?
The data was verified on 2026-08-30. The dataset is valid through 2026-09-06.